The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies

Journal of Pathology - Tập 196 Số 3 - Trang 254-265 - 2002
Lynne Bingle1,2, Nicola J. Brown1, Claire E. Lewis2
1Microcirculation Research Unit, Division of Clinical Sciences, University of Sheffield Medical School, Sheffield S10 2RX, UK
2Tumour Targeting Group, Division of Genomic Medicine, University of Sheffield Medical School, Sheffield S10 2RX, UK

Tóm tắt

Abstract

The role of macrophages in tumour growth and development is complex and multifaceted. Whilst there is limited evidence that tumour‐associated macrophages (TAMs) can be directly tumouricidal and stimulate the anti‐tumour activity of T cells, there is now contrasting evidence that tumour cells are able to block or evade the activity of TAMs at the tumour site. In some cases, tumour‐derived molecules even redirect TAM activities to promote tumour survival and growth. Indeed, evidence has emerged for a symbiotic relationship between tumour cells and TAMs, in which tumour cells attract TAMs and sustain their survival, with TAMs then responding to micro‐environmental factors in tumours such as hypoxia (low oxygen tension) by producing important mitogens as well as various growth factors and enzymes that stimulate tumour angiogenesis. This review presents evidence for the number and/or distribution of TAMs being linked to prognosis in different types of human malignancy. It also outlines the range of pro‐ and anti‐tumour functions performed by TAMs, and the novel therapies recently devised using TAMs to stimulate host immune responses or deliver therapeutic gene constructs to solid tumours. Copyright © 2002 John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

Ross JA, The Macrophage

Virchow R, 1863, Die Krankhaften Geschwulste

van Ravenswaay, 1992, Tumour infiltrating cells in human cancer. On the possible role of CD16+ macrophages in anti‐tumour cytotoxicity, Lab Invest, 67, 166

10.1038/bjc.1978.252

10.1016/0304-419X(86)90011-9

Mantovani A, 1994, Tumour‐associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines, Lab Invest, 71, 5

10.1126/science.2781291

10.1007/s004010050647

10.3171/jns.1995.82.5.0874

10.1172/JCI117933

Riethdorf L, 1996, Differential expression of the monocyte chemoattractant protein‐1 gene in human papillomavirus‐16‐infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri, Am J Pathol, 149, 1469

10.1002/(SICI)1096-9896(199812)186:4<372::AID-PATH204>3.0.CO;2-8

Ueno T, 2000, Significance of macrophage chemo‐attractant protein‐1 on macrophage recruitment, angiogenesis and survival in human breast cancer, Clin Cancer Res, 6, 3282

10.4049/jimmunol.164.2.733

10.1182/blood.V69.5.1409.1409

10.1002/jcb.240500403

10.1093/jnci/86.2.120

10.3109/07853899509031941

Chambers SK, 1997, Overexpression of epithelial macrophage colony‐stimulating factor (CSF‐1) and CSF‐1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF‐1, Clin Cancer Res, 3, 999

10.1002/jlb.56.4.423

Munn DH, 1993, Cytokine regulation of human monocyte differentiation in vitro: the tumour‐cytotoxic phenotype induced by macrophage colony‐stimulating factor is developmentally regulated by γ‐interferon, Cancer Res, 53, 2603

10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G

Yeo KT, 1993, Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumour and inflammatory effusions, Cancer Res, 53, 2912

Leek RD, 1996, Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma, Cancer Res, 56, 4625

10.1136/jcp.50.8.669

10.1016/S0960-9776(98)90065-0

10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F

Lissbrant IF, 2000, Tumour associated macrophages in human prostate cancer: relation to clinicopathological variables and survival, Int J Oncol, 17, 445

Shimura S, 2000, Reduced infiltration of tumour‐associated macrophages in human prostate cancer: association with cancer progression, Cancer Res, 60, 5857

10.1006/gyno.1998.5292

10.1002/(SICI)1097-0215(19991022)84:5<538::AID-IJC17>3.0.CO;2-B

Fujimoto J, 2000, Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers, Cancer Res, 60, 2632

10.1002/(SICI)1097-0215(19990219)84:1<74::AID-IJC14>3.0.CO;2-I

10.1038/bjc.1998.280

10.1046/j.1365-2559.1998.00453.x

10.1046/j.1442-2042.2000.00190.x

Nishie A, 1999, Macrophage infiltration and heme oxygenase‐1 expression correlate with angiogenesis in human gliomas, Clin Cancer Res, 5, 1107

10.1007/BF00688208

10.1136/jcp.41.7.753

10.1073/pnas.83.14.5233

10.1016/S0006-291X(88)80015-9

Keller R, 1990, L‐arginine‐dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages, Cancer Res, 50, 1421

10.1002/jlb.58.4.373

10.4049/jimmunol.150.8.3478

10.1038/sj.bjc.6690118

10.1046/j.1365-2567.1999.00915.x

10.1111/j.1476-5381.1992.tb13412.x

10.1073/pnas.92.10.4392

10.1038/bjc.1995.274

10.1084/jem.179.6.1895

10.1016/S0090-4295(96)00207-5

10.1006/bbrc.1999.1584

10.1073/pnas.56.1.72

10.1126/science.153.3731.80

10.1046/j.1365-2567.1997.00311.x

10.1016/0008-8749(92)90339-Q

10.1002/1097-0142(20000715)89:2<334::AID-CNCR18>3.0.CO;2-N

10.1016/S0950-3536(89)80009-5

10.4049/jimmunol.164.5.2728

10.1016/S0065-2776(08)60387-9

10.1007/978-3-642-80071-9_5

10.1111/j.1749-6632.1996.tb52715.x

10.1177/019262339902700112

10.1073/pnas.93.21.11302

10.1007/978-1-4615-5357-1_55

10.1038/sj.cgt.7700072

10.1038/sj.cgt.7700013

10.4049/jimmunol.164.6.3112

10.1038/sj.gt.3300908

10.1002/1521-4141(200010)30:10<3057::AID-IMMU3057>3.0.CO;2-P

10.1016/0092-8674(94)90200-3

10.1097/00000658-200001000-00010

10.1016/S0092-8674(00)81926-1

10.1074/jbc.272.46.28823

Ferrara N, 1997, Tumour Angiogenesis, 185, 10.1093/oso/9780198549376.003.0016

10.1182/blood.V87.8.3336.bloodjournal8783336

10.1002/(SICI)1096-9896(199801)184:1<31::AID-PATH962>3.0.CO;2-V

10.1084/jem.172.6.1535

Etoh T, 2000, Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration, Clin Cancer Res, 6, 3543

10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.0.CO;2-M

10.1016/S0046-8177(97)90108-8

10.1002/jlb.66.1.40

10.1038/bjc.1995.419

Hildenbrand R, 1998, Transforming growth factor‐β stimulates urokinase expression in tumour‐associated macrophages of the breast, Lab Invest, 78, 59

10.1097/00000658-200106000-00008

10.1002/1097-0215(200002)9999:9999<::AID-IJC1102>3.0.CO;2-Y

10.1002/1097-0142(20010401)91:7<1277::AID-CNCR1129>3.0.CO;2-H

10.1038/bjc.1993.207

Davies B, 1993, Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion, Cancer Res, 53, 5365

10.1002/ijc.2910580110

10.1002/(SICI)1096-9896(199601)178:1<59::AID-PATH418>3.0.CO;2-E

10.1016/S0046-8177(00)80214-2

Edwards RL, 1992, The role of leukocytes in the activation of blood coagulation, Semin Hemato., 29, 202

10.1182/blood.V93.12.4284

Senger DR, 1996, Stimulation of endothelial cell migration by VPF/VEGF through co‐operative mechanisms involving the αVβ3 integrins osteopontin and thrombin, Am J Pathol, 149, 293

10.1111/j.1749-6632.1992.tb51603.x

10.1172/JCI117451

10.1093/jnci/93.4.266

10.1038/sj.bjc.6690158

10.1002/(SICI)1521-4141(199907)29:07<2280::AID-IMMU2280>3.0.CO;2-C

10.1002/jlb.66.6.889

10.1002/jlb.66.6.889

10.1038/71527

Lopez M, 1996, Tumoricidal potential of human macrophages grown in vitro from blood monocytes, J Exp Ther Oncol, 1, 143

10.1007/BF00199221

10.1002/1097-0142(19820801)50:3<498::AID-CNCR2820500319>3.0.CO;2-W

10.1002/eji.1830260620

10.1002/jlb.64.4.419

10.1097/00002371-200011000-00009

10.1007/PL00006671

10.1016/0959-8049(96)00233-X

Bartholeyns J, 1994, Immune control of neoplasia by adoptive transfer of macrophages: potentiality for antigen presentation and gene transfer, Anticancer Res, 14, 2673

10.1016/0277-5379(88)90069-7

10.1038/sj.gt.3301162

Huang S, 1996, Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis, Clin Cancer Res, 2, 1969

10.1038/sj.gt.3301058